Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate, GT-02287 is currently being evaluated for the treatment of Parkinson’s disease with or without a GBA1 mutation. Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma exposure in the projected therapeutic range, CNS exposure, and target engagement and modulation of GCase enzyme.
Gain’s unique approach enables the discovery of novel, allosteric small molecule modulators that can restore or disrupt protein function. Deploying its highly advanced Magellan™ platform, Gain is accelerating drug discovery and unlocking novel disease-modifying treatments for untreatable or difficult-to-treat disorders including neurodegenerative diseases, rare genetic disorders and oncology.
Company Details
- Employees
- 31
- Founded
- -
- Address
- 4800 Montgomery Ln, Suite 220,switzerland
- Phone
- 301-500-1556
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gaintherapeutics.com
- Keywords
- Rare diseases, neurodegenerative diseases, pharmacological chaperones, lysosomal storage disorders, oncology.
- HQ
- Bethesda, Maryland
Gain Therapeutics Questions
Gain Therapeutics's helpline number is 301-500-1556
Gain Therapeutics's website is gaintherapeutics.com
Gain Therapeutics's LinkedIn profile is https://www.linkedin.com/company/gain-therapeutics
Gain Therapeutics has
31 employees.
View email and phone details for 31
employees at Gain Therapeutics.
Gain Therapeutics's industry is
Biotechnology Research
Gain Therapeutics's top competitors are
Alpha Cognition, Inc.,
Rise Therapeutics,
Minoryx Therapeutics,
Kariya Pharmaceuticals,
Neurolixis,
Irb | Institute For Research In Biomedicine,
Grin Therapeutics, Inc.,
Alentis Therapeutics,
Dyne Therapeutics,
Theriva Biologics, Inc..
Gain Therapeutics's support email address is info@gaintherapeutics.com
Gain Therapeutics's categories are Biotechnology Research
Gain Therapeutics's founding year is 2017
